Previous close | 497.80 |
Open | 500.40 |
Bid | 500.00 x 10000 |
Ask | 502.60 x 10000 |
Day's range | 500.40 - 500.40 |
52-week range | 370.00 - 506.20 |
Volume | |
Avg. volume | 3 |
Market cap | 117.207B |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | 20.14 |
EPS (TTM) | 24.84 |
Earnings date | 17 Jul 2024 |
Forward dividend & yield | 6.08 (1.22%) |
Ex-dividend date | 10 Jun 2024 |
1y target est | 436.00 |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Shares of highly rated managed health care provider Elevance Health are rising amid double-digit earnings gains. The upgrade of the RS Rating for Elevance stock to 81 means it topped 81% of all stocks for price performance over the past year. It's a significant upgrade because market research shows that the biggest stock winners typically have an 80 or higher RS Rating as they begin their price moves.